Información de la revista
Más populares
Artículos que han recibido mayor atención en las redes sociales. Número de veces que han sido referenciados en los últimos 3 años.
271
Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerationsMaría-Jimena Muciño-Bermejo
Ann Hepatol. 2020;19:145-52
271
Open access
237
Cannabis use may reduce healthcare utilization and improve hospital outcomes in patients with cirrhosisLindsay A Sobotka, Khalid Mumtaz, Alice Hinton, Sean G Kelly, Lanla F Conteh, Anthony J Michaels, A. James Hanje, Michael R Wellner
Ann Hepatol. 2021;23C:280
237
Open access
171
Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesisAnkita Chatterjee, Analabha Basu, Kausik Das, Pankaj Singh, Dipankar Mondal, Biswanath Bhattacharya, Shweta Roychoudhury, Partha P. Majumder, ... Priyadarshi Basu
Ann Hepatol. 2020;19:472-81
171
Open access
120
Mediterranean-like mix of fatty acids induces cellular protection on lipid-overloaded hepatocytes from western diet fed miceLyssia Castellanos-Tapia, María Elizabeth Tejero-Barrera, Soraya Salas-Silva, Arturo Simoni-Nieves, Alejandro Escobedo-Calvario, Luis E. Gomez-Quiroz
Ann Hepatol. 2020;19:489-96
120
Open access
95
A systematic review and meta-analysis of the COVID-19 associated liver injuryYu Jun Wong, Malcolm Tan, Qishi Zheng, James Weiquan Li, Rahul Kumar, Kwong Ming Fock, Eng Kiong Teo, Tiing Leong Ang
Ann Hepatol. 2020;19:627-34
95
Open access
Artículo abierto
87
A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their managementJulio D. Vorobioff, Fernando Contreras, Federico Tanno, Lucía Hernández, Fernando Bessone, Luis Colombato, José Adi, Eduardo Fassio, ... Martín Garzón
Ann Hepatol. 2020;19:396-403
87
Open access
75
Development of the analytical method for the quantification of 3-nitrotirosin and 3-chlorothyrosin in human plasma as potential biomarkers to evaluate minimal liver encephalopathy (MHE)A. Villaseñor Todd, J.A. Hernández-Hernández, R.C. López-Sanchez, F.J. Bosques-Padilla, C.A. Cortez-Hernandez, E. Lopez Soriano
Ann Hepatol. 2020;19 Supl 1:21
75
Open access
69
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formationQifan Lu, Zhaoyan Jiang, Qihan Wang, Hai Hu, Gang Zhao
Ann Hepatol. 2021;23C:100289
69
Open access
68
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidenceCiro Celsa, Caterina Stornello, Paolo Giuffrida, Carmelo Marco Giacchetto, Mauro Grova, Gabriele Rancatore, Concetta Pitrone, Vito Di Marco, ... Giuseppe Cabibbo
Ann Hepatol. 2022;27 Supl 1:100568
68
Open access
58
An Integrated Review of the Hepatorenal SyndromeAlicia S. Ojeda-Yuren, Eira Cerda-Reyes, Maria R. Herrero-Maceda, Graciela Castro-Narro, Salvatore Piano
Ann Hepatol. 2021;22C:236
58
Open access